✦ LIBER ✦

To match or not to match: the question for chronically transfused patients with sickle cell anemia

✍ Scribed by Paul M. Ness

Book ID: 114439844
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 318 KB
Volume: 34
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1994.34794330007.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experience with donors matched for minor

Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy

✍ D.R. Ambruso; J.H. Githens; R. Alcorn; D.J. Dixon; L.J. Brown; W.M. Vaughn; T. H 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 473 KB

DNA array analysis for red blood cell an

DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease

✍ K. R. Ribeiro; M. H. Guarnieri; D. C. Da Costa; F. F. Costa; J. Pellegrino Jr; L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Manual erythroexchange for chronic trans

Manual erythroexchange for chronic transfusion therapy in patients with sickle cell syndromes unresponsive to hydroxyurea: A long-term follow-up

✍ Paola Carrara; Manuela Balocco; Valeria Pinto; Francesca Olcese; Anna Soldà; Pao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

## Nothing to report. a Costs estimates for a 55-Kg patient based on: STT 5 2: filtered, washed, without buffy coat red blood cell units (250 ml Ht 80%)/ 4 week ? 249/ RBC U € 3 2 5 498 €. Desferoxamine f. 2g ? 11.05 € (40 mg/kg 3 5 days/week 5 11 g/week ? 5 f/ week 3 52 weeks/year). MEEX 5 2: fil

The effect of adding rituximab to CHOP-b

The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis

✍ Hisakazu Nishimori; Keitaro Matsuo; Yoshinobu Maeda; Yuichiro Nawa; Kazutaka Sun 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 201 KB

Daily or three times per week interferon

Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone

✍ Victor de Lédinghen; Pascale Trimoulet; Maria Winnock; Pierre-Henri Bernard; Mar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 107 KB

The Association Of Fludarabin, Oral Busu

The Association Of Fludarabin, Oral Busulfan And Thymoglobulin Prior To Matched Related Allo-SCT Allows For High Long Term Outcome For Both Patients With Myeloid Or Lymphoid Malignancies: Long Term Analysis Of A Homogenous Cohort Of 100 Consecutive Patients

✍ L. Farnault; B. Esterni; C. Faucher; S. Furst; J. El Cheikh; P. Ladaique; N. Vey 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB